Japan Equities: Fiscal and Monetary Policies to Watch Post-Elections
Japan’s ongoing domestic transformation, driven by corporate governance, is likely to support market strength
Chief Investment Office, Joanne Goh24 Jul 2025
  • Japan’s upper house election yielded a minority government for the LDP-led ruling coalition
  • Fiscal policy remains unclear due to diverging approaches of the LDP and opposition parties
  • Delays in fiscal stimulus could prompt a more cautious approach to normalisation by the BOJ
  • Remain neutral on Japan equities, given ongoing domestic transformation and trade deal with the US
  • We maintain our preference on domestic demand-driven equities
Article image
Photo credit: Unsplash
Read More
Japan’s upper house election results largely in line with expectations. Prime Minister Ishiba’s ruling coalition, composed of the Liberal Democratic Party (LDP) and Komeito, secured 47 seats, just shy of the 50 needed for an outright majority. Despite this setback, Ishiba confirmed his intention to remain in office. This has left LDP at the helm of a minority government, requiring support from opposition parties to pass legislations.

This political landscape has several key implications: (i) fiscal and monetary policy directions remain ambiguous and (ii) potential political shifts warrant close observation in the coming months. These include potential internal LDP pressure on Ishiba to resign or a possibility of expanding the ruling coalition to overcome potential legislative gridlock.

One key uncertainty was resolved immediately after the elections with the finalisation of the trade deal with the US which lowered Japan’s tariffs from 25% to 15%, including a noticeable reduction in auto tariffs to the same rate.

Fiscal and monetary policies remain complex. Inflation and rising living costs were dominant themes throughout the election campaign, highlighting the diverging approaches of the LDP and opposition. The LDP favours direct cash subsidies to ease household burdens, while opposition parties advocate for consumption tax cuts, i.e. either a temporary 0% tax on food for one year or a universal cut to 5%. A potential compromise—such as concessions on tax cuts in exchange for opposition support on key legislation—cannot be ruled out.

Persistently high inflation suggests that the Bank of Japan (BOJ) should maintain its course towards policy normalisation. However, delays in fiscal stimulus measures could prompt a more cautious approach from the BOJ. Furthermore, any implementation of consumption tax cuts could raise concerns about fiscal sustainability and drive bond yields higher, potentially requiring the BOJ to maintain a strong presence in the JGB market for an extended period.

We maintain our neutral stance on Japan equities despite these uncertainties as Japan’s ongoing domestic transformation, driven by corporate governance, is likely to support market strength. In the public markets, Japanese corporations have emerged as the largest equity buyers, repurchasing JPY7.9tn (USD50bn) worth of domestic stocks in 2024—a record amount. Buybacks continue into this year with 1H25 exceeding 2024 full-year numbers. A successful trade deal with a lower-than-expected tariff rate offers a potential catalyst for near-term growth in Japan equities.

We continue to prefer:

1. Domestic demand-driven equities as fiscal loosening (via LDP’s supplementary budget or oppositions’ consumption tax cut) will boost domestic consumption. Preferred sectors are outlined below:
  • Technology & Comms. Services: Domestic-focused technology and services such as software and IT services where domestic market is strongly driven by digital transformation and margins improvement via offshoring; internet and digital media companies where growth is driven by local user engagement, advertising, and digital services—these activities are less impacted by tariffs or currency.
  • Cons. Staples: Retailing such as drugstores and supermarkets with strong domestic demand, margin improvement potential, and market share gains.
2. Sectors that have less exposure to exports, currency, and interest rates:
  • Healthcare: Pharmaceutical and medical devices where demand is elastic and are thus, less affected by tariffs or currency fluctuations.
  • Defence: The industry can benefit from government contracts and are less vulnerable to trade and currency fluctuations. Under its five-year plan initiated in 2022, Japan is raising its defence spending to 2% of GDP by 2027 from around 1%.
  • Financials: Banks are undervalued and will continue to benefit from steady profit growth. While insurance is less exposed to trade risks, we are less positive on life insurance companies, given the concerns on balance sheet erosion when bond yields rise, should there be a mismatch in liabilities and assets.
Figure 1: Rising bond yields render the market expensive from yield perspectives

Source: LSEG, DBS

Download the PDF to read the full report.

Topic

Explore more

CIO Perspectives
Disclaimers

This information herein is published by DBS Bank Ltd. (“DBS Bank”) and is for information only.  This publication is intended for DBS Bank and its subsidiaries or affiliates (collectively “DBS”) and clients to whom it has been delivered and may not be reproduced, transmitted or communicated to any other person without the prior written permission of DBS Bank. 

This publication is not and does not constitute or form part of any offer, recommendation, invitation or solicitation to you to subscribe to or to enter into any transaction as described, nor is it calculated to invite or permit the making of offers to the public to subscribe to or enter into any transaction for cash or other consideration and should not be viewed as such.

The information herein may be incomplete or condensed and it may not include a number of terms and provisions nor does it identify or define all or any of the risks associated to any actual transaction. Any terms, conditions and opinions contained herein may have been obtained from various sources and neither DBS nor any of their respective directors or employees (collectively the “DBS Group”) make any warranty, expressed or implied, as to its accuracy or completeness and thus assume no responsibility of it. The information herein may be subject to further revision, verification and updating and DBS Group undertakes no responsibility thereof.

All figures and amounts stated are for illustration purposes only and shall not bind DBS Group. This publication does not have regard to the specific investment objectives, financial situation or particular needs of any specific person. Before entering into any transaction to purchase any product mentioned in this publication, you should take steps to ensure that you understand the transaction and has made an independent assessment of the appropriateness of the transaction in light of your own objectives and circumstances. In particular, you should read all the relevant documentation pertaining to the product and may wish to seek advice from a financial or other professional adviser or make such independent investigations as you consider necessary or appropriate for such purposes. If you choose not to do so, you should consider carefully whether any product mentioned in this publication is suitable for you.  DBS Group does not act as an adviser and assumes no fiduciary responsibility or liability for any consequences, financial or otherwise, arising from any arrangement or entrance into any transaction in reliance on the information contained herein.  In order to build your own independent analysis of any transaction and its consequences, you should consult your own independent financial, accounting, tax, legal or other competent professional advisors as you deem appropriate to ensure that any assessment you make is suitable for you in light of your own financial, accounting, tax, and legal constraints and objectives without relying in any way on DBS Group or any position which DBS Group might have expressed in this document or orally to you in the discussion.

Any information relating to past performance, or any future forecast based on past performance or other assumptions, is not necessarily a reliable indicator of future results.

The information contained in this article has been obtained from sources believed to be reliable, but DBS makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose.

If this publication has been distributed by electronic transmission, such as e-mail, then such transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete, or contain viruses. The sender therefore does not accept liability for any errors or omissions in the contents of the Information, which may arise as a result of electronic transmission. If verification is required, please request for a hard-copy version.

This publication is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation.

If you have received this communication by email, please do not distribute or copy this email. If you believe that you have received this e-mail in error, please inform the sender or contact us immediately. DBS Group reserves the right to monitor and record electronic and telephone communications made by or to its personnel for regulatory or operational purposes. The security, accuracy and timeliness of electronic communications cannot be assured.

Please refer to the Additional Terms and Conditions Governing Digital Tokens for DBS Treasures Customers for more specific risk disclosures on trading of digital tokens.

This information does not constitute or form part of any offer, recommendation, invitation or solicitation to subscribe to or enter into any transaction. It does not have regard to your specific investment objectives, financial situation or particular needs. It is not intended to provide, and should not be relied upon for accounting, legal or tax advice.

Cryptocurrency trading is highly risky and prices can be very volatile. All investments come with risks and you can lose your entire investment. Before you decide to purchase an investment product, you should read all the relevant documents and carefully assess if it is suitable for you. Invest only if you understand and can monitor your investmen. Diversify your investments and avoid investing a large portion of your money in a single asset type.

Trading in Cryptocurrencies or the instrument (“Instrument”), such as ETF, referencing or with underlying as Cryptocurrencies ("Crypto-Products”), such as Bitcoin ETFs, is highly risky and prices can be very volatile. All investments come with risks and you can lose your entire investment. By trading in Crypto-Products, you are exposed to the risks of both the Instrument and the Cryptocurrencies. Further, Crypto-Products listed on overseas exchanges may not be regulated in Singapore, and are subject to the laws and regulations of the jurisdiction it is listed in. Before you decide to buy or sell Cryptocurrencies or Crypto-Products, you should read all the relevant documents and carefully assess if it is suitable for you and/or seek advice from a financial adviser regarding its suitability. Invest only if you understand and can monitor your investment. Diversify your investments and avoid investing a large portion of your money in a single asset type.

To the extent permitted by law, DBS accepts no liability whatsoever for any direct, indirect or consequential losses or damages arising from or in connection with the use or reliance of this email or its contents. If this information has been distributed by electronic transmission, such as e-mail, then such transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete, or contain viruses.

Please refer to Terms and Conditions governing your banking relationship with DBS for more specific risk disclosures on the Instrument (such as ETFs under Funds) and Digital Tokens.

This information is provided to you as an “Accredited Investor” (defined under the Securities and Futures Act of Singapore and the Securities and Futures (Classes of Investors) Regulations 2018) for your private use only. It is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation, and may not be passed on or disclosed to any person nor copied or reproduced in any manner. 

DBS (Company Registration. No. 196800306E) is an Exempt Financial Adviser as defined in the Financial Advisers Act and regulated by the Monetary Authority of Singapore (the "MAS")